Application of tumor size modelling and simulations to support the dose selection of BI 907828 for a Phase II study PAGE 31 (2023) Abstr 10465 Neldemo I, Sarr C, Friberg L, Sailer R, Lamar M. Jayadeva G, Pérez-Pitarch A, Busse D. ConferenceMIDDOncologyPharmacometrics Pharmetheus Affiliates Senior Consultant Ida Neldemo See bio Principal Consultant & Team Leader Céline Sarr See bio Scientific Advisor Lena Friberg See bio
